SAS launches solution to speed drug development process
SAS, the market leader in business intelligence software and services, has launched SAS Drug Development 3.0. Based on the capabilities of the SAS 9 Intelligence Platform, SAS Drug Development provides a centralized repository that allows life sciences firms to analyse their clinical research for regulatory submission and explore new market opportunities, product line extensions and safety issues — all within a controlled and secure collaborative framework designed for life sciences research industries.